Претраживање
Приказ резултата 1-10 од 199
Circulating non-coding RNAs as biomarkers in coronary artery disease / Cirkulišuće nekodirajuće RNK kao biomarkeri u koronarnoj arterijskoj bolesti
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
Coronary artery disease (CAD) is a leading cause of mortality worldwide. Atherosclerosis
involves an interplay of different pathological mechanisms, such as progressive inflammation,
abnormal lipid metabolism, and oxidative ...
Telomere length as a biomarker of aging and diseases / Dužina telomera kao biomarker starenja i bolesti
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
As research related to healthspan and lifespan has become a hot topic, the necessity for a
reliable and practical biomarker of aging (BoA), which can provide information about mortality
and morbidity risk, along with ...
Liquisolid systems: Evaluation of the influence of formulation variables on the optimum liquid load / Tečno-čvrsti sistemi: Ispitivanje uticaja faktora formulacije na optimalno opterećenje tečnošću
(Pharmaceutical Association of Serbia, 2022)
Liquisolid systems represent an emerging approach in the preparation of solid dosage forms with liquid lipophilic drug or poorly water-soluble drug solution/suspension in suitable liquid vehicle. This study addresses the ...
Biomarkers of dyslipidemia in patients with diabetic foot / Biomarkeri dislipidemije kod pacijenata sa dijabetesnim stopalom
(Beograd : Savez farmaceutskih udruženja Srbije, 2022)
Diabetic foot (DF) is one of the most severe complications of diabetes that significantly
reduces the quality of life and survival of patients. Besides firmly established risk factors, novel
data indicate that alterations ...
Does Pentraxin-3 contribute to the reduction of low-density lipoprotein levels by statin therapy? / Da li pentraksin -3 doprinosi sniženju koncentracije lipoproteina niske gustine i terapiji statinima?
(Pharmaceutical Association of Serbia, 2022)
Statins have been shown to decrease inflammatory markers, especially high sensitivity C reactive protein (hsCRP), in a dose-dependent manner. Pentraxin-3 (PTX3) is another important inflammatory biomarker from the pentraxin ...
Why is there a need for cosmetics safety risk assessment? / Zašto je potrebna toksikološka procena rizika za kozmetički proizvod?
(Savez farmaceutskih udruženja Srbije, Beograd, 2018)
Bearing in mind that cosmetic products are applied throughout the lifetime and that they can contain potentially harmful and toxic substances, valid EU regulation in this area has set strict requirements regarding their ...
Hormonelike substances from plants / Hormonima slični sastojci biljaka
(Savez farmaceutskih udruženja Srbije, Beograd, 2010)
The plants are not capable to synthesise substances with the same chemical structure like hormones from humans or animals. But it is quite clear that substances which can influence the homeostasis of hormones in other ...
Research on presence of chosen risk factors for hypertension in medical students / Ispitivanje zastupljenosti odabranih faktora rizika za razvoj hipertenzije u populaciji studenata medicinskih fakulteta
(Univerzitet u Prištini - Medicinski fakultet, Kosovska Mitrovica, 2015)
Hypertension represents one of the most significant preventable causes of death worldwide, and accordingly the target group for its prevention and early detection primarily refers to young population. Assessment of prevalence ...
Fungi and Helicobacter pylori infection / Gljive i Helicobacter pylori infekcija
(Društvo za ishranu Srbije, Beograd, 2015)
Helicobacter pylori is a Gram-negative bacterium that colonizes the stomach almost half the world's population. Infection of the stomach with this bacteria leads to chronic gastritis and peptic ulcer disease. Further, long ...
Hormones as biotech-drugs: Human insulin and insulin analogues / Hormoni kao biotehnološki lekovi - humani insulin i analozi
(Savez farmaceutskih udruženja Srbije, Beograd, 2010)
Biotech-drugs or biopharmaceuticals are proteins or nucleic acids, which have been produced by living organisms as a result of biotechnology. Three decades after the beginning steps, they make a third part of all new drugs ...